The exponential growth of the digital health products industry has brought an array of options for helping patients to prevent, manage and treat medical conditions. A subset of this trend, digital therapeutics, can be used independently or along with medications, devices, or other therapies across a variety of disease states. They also can capture real world data on usage, engagement, disease progression, healthcare outcomes and therapeutic efficiency.
With the increasing adoption of digital tools and the ongoing need to monitor both healthcare costs and the rising incidence in chronic diseases, it is worth asking: Are US payers prepared to evaluate and determine coverage for these products?
Join this free webinar for an overview of the digital health landscape and details from ICON’s in-depth interviews with health plan and pharmacy benefit manager leaders. Attendees will gain insights on what to expect from US payers and how digital health manufacturers can be successful in this rapidly expanding market.
Benjamin Schatzman, PharmD, Principal, Global Pricing and Market Access, ICON
Dr Benjamin Schatzman has over 21 years of managed care pharmacy experience, including PBM and Managed Care. His expertise includes formulary management, medical policy, payer access, health plan pharmacy operations, regulatory and governmental affairs work pertaining to pharmacy, PBM and specialty pharmacy oversight, as well as government-sponsored health plans including Medicaid, Medicare and Health Insurance Exchange. Prior to joining ICON, Dr Schatzman was Vice President of Pharmacy Plan Operations and Clinical Support at Molina Healthcare, a Fortune 500 company, where he helped oversee a $3 billion-plus pharmacy benefit.Message Presenter
Curran Sidhu, Senior Analyst, Global Pricing and Market Access, ICON
Mr Curran Sidhu works with global pharma and medical device clients on projects involving value proposition development, pricing and market access strategy and reimbursement strategy. His experience spans several therapeutic areas including oncology, diabetes, immunology, ophthalmology, and orthopedics.Message Presenter
Who Should Attend?
This program is intended for professionals from pharmaceutical, biotech and medical device companies involved in:
- Digital therapeutics
- Health economics & outcomes research (HEOR)
- Market access
- Medical affairs
- Regulatory affairs
ICON plc is a global provider of outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specializes in the strategic development, management and analysis of programs that support clinical development. With headquarters in Dublin, Ireland, ICON currently operates from 98 locations in 40 countries and has approximately 15,100 employees. Further information is available at ICONplc.com.